4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004240
Options or other derivatives
- SVP, CHIEF LEGAL OFFICER acquired 48,067 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +6,050 | 17,409 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +4,698 | 7,365 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Unit | +7,269 | 7,269 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +30,050 | 30,050 | D | ||
Loading xslF345X05/form4-02142025_110259.xml…